Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Advanced Non-Small Cell Lung Cancer
NCT00300729Phase 3Unknown
- Start
- May 2006
- Primary completion
- May 2010
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of celecoxib oral solution in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
celecoxib oral solution
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00300729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300729.